Cargando…
Crenigacestat (LY3039478) inhibits osteogenic differentiation of human valve interstitial cells from patients with aortic valve calcification in vitro
Calcific aortic valve disease (CAVD) is one of the dangerous forms of vascular calcification. CAVD leads to calcification of the aortic valve and disturbance of blood flow. Despite high mortality, there is no targeted therapy against CAVD or vascular calcification. Osteogenic differentiation of valv...
Autores principales: | Lobov, Arseniy A., Boyarskaya, Nadezhda V., Kachanova, Olga S., Gromova, Ekaterina S., Shishkova, Anastassia A., Zainullina, Bozhana R., Pishchugin, Alexander S., Filippov, Alexey A., Uspensky, Vladimir E., Malashicheva, Anna B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556293/ https://www.ncbi.nlm.nih.gov/pubmed/36247471 http://dx.doi.org/10.3389/fcvm.2022.969096 |
Ejemplares similares
-
Multi-omics of in vitro aortic valve calcification
por: Semenova, Daria, et al.
Publicado: (2022) -
A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2020) -
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
por: Even, C., et al.
Publicado: (2019) -
The Role of the Notch Signaling Pathway in Recovery of Cardiac Function after Myocardial Infarction
por: Kachanova, Olga, et al.
Publicado: (2022) -
Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
por: Kostyunin, Alexander E., et al.
Publicado: (2022)